Mode
Text Size
Log in / Sign up
N/A N=69

Retrospective Health Care Utilisation and Current Quality of Life in Adults With Chronic Otitis Media Who Had a Middle Ear Surgery

Chronic Otitis Media

Enrolled (actual)
69
Serious AEs
Results posted
Mar 2025
Primary outcome: Primary: Number and Type of Contacts With Health Care Providers — 45; 14; 5; 3 Participants

Study Design & Population

Study type
Observational
Phase
N/A
Interventions
Questionnaires and survey (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Cochlear
Primary completion
Oct 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Number and Type of Contacts With Health Care Providers
45; 14; 5; 3; 2; 45
PRIMARY
Number and Type of Interventions and/or Procedures
12; 23; 14; 65; 25; 18
PRIMARY
Number and Type of Medications and Therapies
20; 1; 14; 3; 1; 4
SECONDARY
Hearing Performance Assessed Via an Audiogram
56.7; 25.2
SECONDARY
Hearing Performance Assessed Via an Audiogram
56.7; 25.2
SECONDARY
Hearing Performance Assessed Via an Audiogram
56.7; 25.2
SECONDARY
Health Care Costs
SECONDARY
Socio-economic Status and Health Care Data Via the Client Service Receipt Inventory (CSRI) Survey
41; 14; 7; 6; 24; 19
SECONDARY
Self-reported Health Status and Health Related Quality of Life Via the Health Utilities Index Mark III (HUI3) Questionnaire.
0.7; 0.9; 0.8; 0.9; 1; 0.9
SECONDARY
Self-reported Health Related Quality of Life of Participants With COM Via the Chronic Otitis Media Outcome Test-15 (COMOT-15) Questionnaire.
43; 29.4; 65; 46.5
SECONDARY
Self-reported Auditory Disability Via the Speech, Spatial and Qualities of Hearing Scale (SSQ-12) Questionnaire
5.5
SECONDARY
Chronic Otitis Media Outcome Test -15 (COMOT-15) Questionnaire in German, French and Spanish
36.8; 46.3; 45

Summary

The objective of this multicentre study is to evaluate the standard of care of participants diagnosed with Chronic Otitis Media that have already gone through a first middle ear surgery but still have at least a moderate hearing loss. The study has a retrospective part (extraction of medical chart data) and a prospective part with a survey and three questionnaires collecting data on the use of health care services, on health related quality of life and hearing performance.

Eligibility Criteria

Inclusion Criteria

  • Adult subjects, 18 years or older.
  • Subjects with conductive or mixed hearing loss.
  • Subjects with historically documented diagnosis of Chronic Otitis Media (COM) with or without cholesteatoma in the operated ear.
  • Subjects who have undergone primary tympanoplasty type I-V to improve hearing between 2010-2016.
  • Subjects with a Pure Tone Average (PTA)4 air-bone gap ≥30 decibels (dB) OR PTA4 air-bone gap between 25-30 dB with an air conduction threshold PTA4 ≥40 dB HL within 12 months after primary tympanoplasty in the operated ear.
  • Subjects who have been recommended by their health care professional to try a hearing aid to improve hearing in the operated ear.
  • Pre-op audiogram, maximum 1 year prior to the primary tympanoplasty, and post-op audiogram for the primary tympanoplasty are available.
  • Aided audiogram, unaided if no hearing device is used, available between 2018 and the point of enrolment.
  • Subjects are fluent in the language used for study questionnaires: German, French, Spanish.
  • Subjects are willing and able to provide written informed consent. For France: subjects do not oppose to participate in the study.
  • Medical Record data is available throughout the defined data search period, from primary tympanoplasty to point of enrolment.

Exclusion Criteria

  • Subjects are unable or unwilling to comply with the requirements of the study as determined by the investigator.
  • Investigator site personnel directly affiliated with this study and/or their immediate families; immediate family is defined as a spouse, parent, child, or sibling.
  • Cochlear employees or employees of Contract Research Organizations or contractors engaged by Cochlear for the purposes of this study.

For France only:

  • Subjects who are not affiliated to social security.
  • Subjects who are under legal protection.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04864912). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search